Literature DB >> 9733497

Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).

D G Kingston1, A G Chaudhary, M D Chordia, M Gharpure, A A Gunatilaka, P I Higgs, J M Rimoldi, L Samala, P G Jagtap, P Giannakakou, Y Q Jiang, C M Lin, E Hamel, B H Long, C R Fairchild, K A Johnston.   

Abstract

The anticancer drug paclitaxel (Taxol) has been converted to a large number of 2-debenzoyl-2-aroyl derivatives by three different methods. The bioactivities of the resulting analogues were determined in both tubulin polymerization and cytotoxicity assays, and several analogues with enhanced activity as compared with paclitaxel were discovered. Correlation of cytotoxicity in three cell lines with tubulin polymerization activity showed reasonable agreement. Among the cell lines examined, the closest correlation with antitubulin activity was observed with a human ovarian carcinoma cell line.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733497     DOI: 10.1021/jm980229d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Drug discovery targeting cell division proteins, microtubules and FtsZ.

Authors:  Iwao Ojima; Kunal Kumar; Divya Awasthi; Jacob G Vineberg
Journal:  Bioorg Med Chem       Date:  2014-03-05       Impact factor: 3.641

2.  Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation.

Authors:  Younkee Paik; Chao Yang; Belhu Metaferia; Shoubin Tang; Susan Bane; Rudravajhala Ravindra; Natasha Shanker; Ana A Alcaraz; Scott A Johnson; Jacob Schaefer; Robert D O'Connor; Lynette Cegelski; James P Snyder; David G I Kingston
Journal:  J Am Chem Soc       Date:  2007-01-17       Impact factor: 15.419

3.  Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH3, 3-CF3O and 3-CHF2O groups at the C2-benzoate position.

Authors:  Changwei Wang; Xin Wang; Yi Sun; Adam K Taouil; Su Yan; Galina I Botchkina; Iwao Ojima
Journal:  Bioorg Chem       Date:  2019-12-20       Impact factor: 5.275

4.  Bridging converts a noncytotoxic nor-paclitaxel derivative to a cytotoxic analogue by constraining it to the T-Taxol conformation.

Authors:  Shoubin Tang; Chao Yang; Peggy Brodie; Susan Bane; Rudravajhala Ravindra; Shubhada Sharma; Yi Jiang; James P Snyder; David G I Kingston
Journal:  Org Lett       Date:  2006-08-31       Impact factor: 6.005

5.  Design, synthesis, and biological evaluation of new-generation taxoids.

Authors:  Iwao Ojima; Jin Chen; Liang Sun; Christopher P Borella; Tao Wang; Michael L Miller; Songnian Lin; Xudong Geng; Larisa Kuznetsova; Chuanxing Qu; David Gallager; Xianrui Zhao; Ilaria Zanardi; Shujun Xia; Susan B Horwitz; Jon Mallen-St Clair; Jennifer L Guerriero; Dafna Bar-Sagi; Jean M Veith; Paula Pera; Ralph J Bernacki
Journal:  J Med Chem       Date:  2008-05-09       Impact factor: 7.446

Review 6.  Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.

Authors:  Iwao Ojima; Xin Wang; Yunrong Jing; Changwei Wang
Journal:  J Nat Prod       Date:  2018-02-22       Impact factor: 4.050

7.  Synthesis and Cytotoxicity of 7,9-O-Linked Macrocyclic C-Seco Taxoids.

Authors:  Yu Zhao; Tian-En Wang; Alberto Mills; Federico Gago; Wei-Shuo Fang
Journal:  Molecules       Date:  2019-06-08       Impact factor: 4.411

Review 8.  Prodrug Strategies for Paclitaxel.

Authors:  Ziyuan Meng; Quanxia Lv; Jun Lu; Houzong Yao; Xiaoqing Lv; Feng Jiang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-05-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.